Population-Based Analysis Of The Use Of Radium-223 For Bone-Metastatic Castration-Resistant Prostate Cancer In Ontario, And Of Factors Associated With Treatment Completion And Outcome.
Cheng S, Arciero V, Goldberg H, Tajzler C, Manganaro A, Kozlowski N, Rowbottom L, McDonald R, Chow R, Vasisht G, Shaji S, Wong ECL, Petrovic M, Zhang L, Phillips C, Zalewski P, Kapoor A, Fleshner NE, Chow E, Emmenegger U.
Cheng S, et al. Among authors: arciero v.
Cancer Manag Res. 2019 Oct 31;11:9307-9319. doi: 10.2147/CMAR.S213051. eCollection 2019.
Cancer Manag Res. 2019.
PMID: 31802949
Free PMC article.